The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of standard vs reduced dosing of sotorasib on efficacy and toxicity in KRAS G12C–mutated advanced non-small cell lung cancer: A systematic review and meta-analysis.
 
Wint Yan Aung
No Relationships to Disclose
 
Melissa Neumann
No Relationships to Disclose
 
Kevin Wang
No Relationships to Disclose
 
Divya Chukkalore
No Relationships to Disclose
 
Jaclyn Morales
No Relationships to Disclose
 
Nagashree Seetharamu
Honoraria - Amgen; Array BioPharma; AstraZeneca/MedImmune; Blueprint Medicines; Boehringer Ingelheim; Boehringer Ingelheim; Genentech; Janssen Oncology; Jazz Pharmaceuticals; Mirati Therapeutics; Pfizer; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca; Blueprint Medicines; Boehringer Ingelheim; Genentech; Mirati Therapeutics; Regeneron; Takeda